Adnan M. M. Mjalli,Bapu Gaddam,Dharma Rao Polisetti,Matthew J. Kostura,Mustafa Guzel
申请号：
US16507219
公开号：
US20190336506A1
申请日:
2019.07.10
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4 including, but not limited to, allergic rhinitis.
